Viremia control following antiretroviral treatment and therapeutic immunizationduring primary SIV251 infection of macaques (Q57089576)

0 references

Monita Poudyal

0 references

Wen-Po Tsai

0 references

Laura Giuliani

0 references

Ruth Woodward

0 references

Claire Chougnet

0 references

Gene Shearer

0 references

John D. Altman

0 references

Norbert Bischofberger

0 references

Alashle Abimiku

0 references

Phillip Markham

0 references

James Tartaglia

0 references

Genoveffa Franchini

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

0 references

language of work or name

English

0 references

publication date

October 2000

0 references

0 references

0 references

0 references

1140-1146

0 references

cites work

1 reference

Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy

21 January 2018

1 reference

Recovery of Replication-Competent HIV Despite Prolonged Suppression of Plasma Viremia

21 January 2018

1 reference

HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression

21 January 2018

1 reference

Control of HIV despite the Discontinuation of Antiretroviral Therapy

21 January 2018

1 reference

HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy

21 January 2018

1 reference

HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides

21 January 2018

1 reference

Major expansion of CD8+ T cells with a predominant V beta usage during the primary immune response to HIV.

21 January 2018

1 reference

Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8+ and CD4+ T lymphocytes

21 January 2018

1 reference

Vigorous HIV-1-Specific CD4 + T Cell Responses Associated with Control of Viremia

21 January 2018

1 reference

HIV-1 antigen-specific and -nonspecific B cell responses are sensitive to combination antiretroviral therapy

21 January 2018

1 reference

A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seronegative volunteers

21 January 2018

1 reference

Immunization with a modified vaccinia virus expressing simian immunodeficiency virus (SIV) Gag-Pol primes for an anamnestic Gag-specific cytotoxic T-lymphocyte response and is associated with reduction of viremia after SIV challenge

21 January 2018

1 reference

Highly attenuated HIV type 2 recombinant poxviruses, but not HIV-2 recombinant Salmonella vaccines, induce long-lasting protection in rhesus macaques

21 January 2018

1 reference

Sequence of simian immunodeficiency virus and its relationship to the human immunodeficiency viruses

21 January 2018

1 reference

The relationship between T cell proliferative responses and plasma viremia during treatment of human immunodeficiency virus type 1 infection with combination antiretroviral therapy

21 January 2018

1 reference

Strong human immunodeficiency virus (HIV)-specific CD4+ T cell responses in a cohort of chronically infected patients are associated with interruptions in anti-HIV chemotherapy

21 January 2018

1 reference

Apoptosis of CD8+ T cells is mediated by macrophages through interaction of HIV gp120 with chemokine receptor CXCR4.

21 January 2018

1 reference

Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein

21 January 2018

1 reference

Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120.

21 January 2018

1 reference

HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression

21 January 2018

1 reference

Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl)adenine

21 January 2018

1 reference

NYVAC: a highly attenuated strain of vaccinia virus

21 January 2018

1 reference

Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys

21 January 2018

1 reference

Rational interleukin 2 therapy for HIV positive individuals: daily low doses enhance immune function without toxicity

21 January 2018

1 reference

Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus

21 January 2018

1 reference

NASBA technology: isothermal RNA amplification in qualitative and quantitative diagnostics

21 January 2018

1 reference

Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection

21 January 2018

1 reference

7 January 2021

Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease

1 reference

7 January 2021

Recombinant vaccine-induced protection against the highly pathogenic simian immunodeficiency virus SIV(mac251): dependence on route of challenge exposure.

1 reference

7 January 2021

A high frequency of Mamu-A*01 in the rhesus macaque detected by polymerase chain reaction with sequence-specific primers and direct sequencing

1 reference

7 January 2021

The CD8+ T lymphocyte response during primary SIVmac infection

1 reference

7 January 2021